Back to Agenda
Models of Collaborations to Advance Regulatory Science: Lessons Learned
Session Chair(s)
Huong Huynh, PhD
Director of Regulatory Science
Critical Path Institute, United States
Regulatory science is a rapidly evolving field with emerging technologies. This session explores collaborative models in drug development and highlights lessons-learned and factors for effective collaborations in advancing regulatory science.
Learning Objective : Discuss models and management of collaborative partnerships to advance novel therapies for patients; Describe strategies to help optimize cross-functional team engagement and multidisciplinary interactions.
Speaker(s)
Panelist
Carla Rodriguez-Watson, PhD, MPH
Reagan-Udall Foundation for the FDA, United States
Panelist
Allison Cuff Shimooka, MBA
TransCelerate Biopharma Inc, United States
Chief Operating Officer

Panelist
Representative Invited
FDA, United States
Have an account?